Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.0K
CRISPR01:59

CRISPR

52.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.2K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

48
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel Lu<sub>2</sub>SrAl<sub>4</sub>SiO<sub>12</sub>:Sm<sup>3+</sup> orange-red phosphor with ultra-high color purity for WLEDs and anti-counterfeiting inks.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Targeted DNA triplex-forming oligonucleotide liposome for pulmonary fibrosis gene therapy.

Cell reports. Medicine·2026
Same author

Nanogel-coated nanozymes for ulcerative colitis targeted treatment by restoring redox homeostasis and anti-inflammatory activity.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Relative ordered structure evaluation of water-extracted polysaccharides from Morchella sextelata: Geographical origins and compositional elements.

International journal of biological macromolecules·2026
Same author

A Split sfGFP-Based Signal-Amplified Reporter System for Enhanced Detection of Promoter Activity.

Biotechnology journal·2026
Same author

Development and structure-guided characterization of a novel ACE2-binding macrocyclic peptide.

Journal of structural biology: X·2026

Related Experiment Video

Updated: Jul 17, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.9K

Mini-PE, a prime editor with compact Cas9 and truncated reverse transcriptase.

Ting Lan1,2, Huangyao Chen1,3,2, Chengcheng Tang1

  • 1Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Wuyi University, Jiangmen 529020, China.

Molecular Therapy. Nucleic Acids
|September 8, 2023
PubMed
Summary
This summary is machine-generated.

Researchers developed a mini-prime editor (PE) by optimizing the Moloney murine leukemia virus (MMLV) reverse transcriptase (RT). This smaller PE tool enables precise gene editing in cells and mouse retinas, paving the way for potential genetic disease therapies.

Keywords:
AAVCjCas9MT: RNA/DNA Editingminiatureprime editortruncated MMLV

More Related Videos

A Nonsequencing Approach for the Rapid Detection of RNA Editing
08:50

A Nonsequencing Approach for the Rapid Detection of RNA Editing

Published on: April 21, 2022

2.6K
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
08:37

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

7.7K

Related Experiment Videos

Last Updated: Jul 17, 2025

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.9K
A Nonsequencing Approach for the Rapid Detection of RNA Editing
08:50

A Nonsequencing Approach for the Rapid Detection of RNA Editing

Published on: April 21, 2022

2.6K
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
08:37

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

7.7K

Area of Science:

  • Molecular Biology
  • Gene Editing Technologies
  • Biotechnology

Background:

  • Prime editing (PE) is a powerful genome editing technology that allows for precise DNA modifications without requiring DNA donors or inducing double-strand breaks.
  • The large size of current prime editor systems poses a significant challenge for efficient in vivo delivery and application.
  • Developing smaller, more manageable prime editor variants is crucial for advancing in vivo gene editing therapies.

Purpose of the Study:

  • To engineer a miniaturized prime editor (mini-PE) system with enhanced delivery capabilities for in vivo applications.
  • To identify and optimize key components of the prime editor, specifically the reverse transcriptase (RT) domain.
  • To evaluate the efficiency and precision of the developed mini-PE in cellular and animal models.

Main Methods:

  • Screening of truncated Moloney murine leukemia virus (MMLV) reverse transcriptase (RT) variants, including those with the F155Y mutation, to identify smaller, efficient components.
  • Optimization of pegRNAs and incorporation of nicking sgRNAs to enhance the editing activity of the mini-PE system.
  • Delivery of the mini-PE system using adeno-associated viruses (AAVs) for in vivo gene editing in mouse models.

Main Results:

  • Identified the smallest functional truncated MMLV RT variants that retain high gene editing efficiency.
  • The optimized mini-PE system achieved up to 10% precise editing at target sites in human and mouse cells.
  • Demonstrated successful in vivo editing of the mouse Hsf1 gene in the retina using AAV delivery, albeit with efficiencies below 1%.

Conclusions:

  • A miniaturized prime editor (mini-PE) has been successfully developed by optimizing MMLV RT, enabling efficient gene editing in vitro.
  • The mini-PE system shows promise for in vivo gene editing applications, as demonstrated by editing in the mouse retina.
  • Further improvements in editing efficiency are needed to fully exploit the therapeutic potential of mini-PE for human genetic diseases.